The Swiss Glucose Variability Study

Summary

The purpose of this study is to explore long term glucose variability of a combination therapy of metformin and vildagliptin compared to a metformin - gliclazide combination. Multicenter, randomized, open, parallel group, Phase IV study, of 18 months duration. * Trial with medicinal product

Timeline

Start

2011-04

Primary completion

2013-01

Completion

2013-01

Drugs

Indications